nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—osteoarthritis—Prednisone—prostate cancer	0.283	1	CpDpCtD
Etodolac—RXRA—prostate cancer	0.264	0.875	CbGaD
Etodolac—PTGS2—prostate cancer	0.0377	0.125	CbGaD
Etodolac—UGT2B7—Epirubicin—prostate cancer	0.03	0.149	CbGbCtD
Etodolac—ALB—Abiraterone—prostate cancer	0.0283	0.141	CbGbCtD
Etodolac—ALB—Estrone—prostate cancer	0.0205	0.102	CbGbCtD
Etodolac—CYP2C9—Bicalutamide—prostate cancer	0.0184	0.0914	CbGbCtD
Etodolac—CYP2C9—Nilutamide—prostate cancer	0.0184	0.0914	CbGbCtD
Etodolac—SLC22A6—Conjugated Estrogens—prostate cancer	0.0157	0.078	CbGbCtD
Etodolac—PTGS2—Etoposide—prostate cancer	0.0122	0.0604	CbGbCtD
Etodolac—ALB—Estradiol—prostate cancer	0.0117	0.0584	CbGbCtD
Etodolac—CYP2C9—Estrone—prostate cancer	0.011	0.0548	CbGbCtD
Etodolac—PTGS1—Etoposide—prostate cancer	0.0103	0.051	CbGbCtD
Etodolac—ALB—Prednisone—prostate cancer	0.0101	0.0502	CbGbCtD
Etodolac—CYP2C9—Capecitabine—prostate cancer	0.00835	0.0415	CbGbCtD
Etodolac—CYP2C9—Estradiol—prostate cancer	0.00633	0.0315	CbGbCtD
Etodolac—UGT1A10—renal system—prostate cancer	0.00164	0.17	CbGeAlD
Etodolac—RXRA—renal system—prostate cancer	0.000976	0.102	CbGeAlD
Etodolac—UGT2B7—prostate gland—prostate cancer	0.000972	0.101	CbGeAlD
Etodolac—CYP2C9—urine—prostate cancer	0.000967	0.101	CbGeAlD
Etodolac—UGT1A9—renal system—prostate cancer	0.000822	0.0855	CbGeAlD
Etodolac—UGT2B7—renal system—prostate cancer	0.000662	0.0689	CbGeAlD
Etodolac—UGT2B7—testis—prostate cancer	0.000428	0.0446	CbGeAlD
Etodolac—PTGS1—prostate gland—prostate cancer	0.000317	0.033	CbGeAlD
Etodolac—PTGS2—prostate gland—prostate cancer	0.000303	0.0315	CbGeAlD
Etodolac—PTGS1—seminal vesicle—prostate cancer	0.000268	0.0279	CbGeAlD
Etodolac—PTGS2—seminal vesicle—prostate cancer	0.000256	0.0267	CbGeAlD
Etodolac—ALB—testis—prostate cancer	0.000245	0.0255	CbGeAlD
Etodolac—PTGS1—epithelium—prostate cancer	0.000233	0.0242	CbGeAlD
Etodolac—PTGS2—epithelium—prostate cancer	0.000223	0.0232	CbGeAlD
Etodolac—PTGS1—renal system—prostate cancer	0.000216	0.0225	CbGeAlD
Etodolac—PTGS2—renal system—prostate cancer	0.000207	0.0215	CbGeAlD
Etodolac—PTGS2—urethra—prostate cancer	0.000203	0.0211	CbGeAlD
Etodolac—ALB—lymph node—prostate cancer	0.000178	0.0185	CbGeAlD
Etodolac—PTGS2—bone marrow—prostate cancer	0.000156	0.0163	CbGeAlD
Etodolac—PTGS1—testis—prostate cancer	0.00014	0.0145	CbGeAlD
Etodolac—PTGS1—lymph node—prostate cancer	0.000101	0.0105	CbGeAlD
Etodolac—PTGS2—lymph node—prostate cancer	9.68e-05	0.0101	CbGeAlD
Etodolac—Malaise—Prednisone—prostate cancer	2.83e-05	0.000261	CcSEcCtD
Etodolac—Shock—Capecitabine—prostate cancer	2.83e-05	0.000261	CcSEcCtD
Etodolac—Rhinitis—Epirubicin—prostate cancer	2.83e-05	0.000261	CcSEcCtD
Etodolac—Abdominal pain—Etoposide—prostate cancer	2.83e-05	0.000261	CcSEcCtD
Etodolac—Body temperature increased—Etoposide—prostate cancer	2.83e-05	0.000261	CcSEcCtD
Etodolac—Conjunctivitis—Doxorubicin—prostate cancer	2.83e-05	0.000261	CcSEcCtD
Etodolac—Vertigo—Prednisone—prostate cancer	2.82e-05	0.00026	CcSEcCtD
Etodolac—Haemorrhage—Epirubicin—prostate cancer	2.82e-05	0.00026	CcSEcCtD
Etodolac—Hepatitis—Epirubicin—prostate cancer	2.82e-05	0.00026	CcSEcCtD
Etodolac—Thrombocytopenia—Capecitabine—prostate cancer	2.82e-05	0.00026	CcSEcCtD
Etodolac—Syncope—Prednisone—prostate cancer	2.82e-05	0.00026	CcSEcCtD
Etodolac—Tachycardia—Capecitabine—prostate cancer	2.81e-05	0.000259	CcSEcCtD
Etodolac—Pharyngitis—Epirubicin—prostate cancer	2.8e-05	0.000258	CcSEcCtD
Etodolac—Sweating—Doxorubicin—prostate cancer	2.79e-05	0.000257	CcSEcCtD
Etodolac—Hyperhidrosis—Capecitabine—prostate cancer	2.78e-05	0.000257	CcSEcCtD
Etodolac—Hypotension—Docetaxel—prostate cancer	2.78e-05	0.000256	CcSEcCtD
Etodolac—Haematuria—Doxorubicin—prostate cancer	2.77e-05	0.000256	CcSEcCtD
Etodolac—Loss of consciousness—Prednisone—prostate cancer	2.76e-05	0.000255	CcSEcCtD
Etodolac—Anorexia—Capecitabine—prostate cancer	2.74e-05	0.000253	CcSEcCtD
Etodolac—Nausea—Estradiol—prostate cancer	2.74e-05	0.000253	CcSEcCtD
Etodolac—Vomiting—Mitoxantrone—prostate cancer	2.73e-05	0.000252	CcSEcCtD
Etodolac—Sinusitis—Doxorubicin—prostate cancer	2.73e-05	0.000252	CcSEcCtD
Etodolac—Convulsion—Prednisone—prostate cancer	2.72e-05	0.000251	CcSEcCtD
Etodolac—Visual impairment—Epirubicin—prostate cancer	2.72e-05	0.000251	CcSEcCtD
Etodolac—Agranulocytosis—Doxorubicin—prostate cancer	2.71e-05	0.00025	CcSEcCtD
Etodolac—Hypertension—Prednisone—prostate cancer	2.71e-05	0.00025	CcSEcCtD
Etodolac—Rash—Mitoxantrone—prostate cancer	2.71e-05	0.00025	CcSEcCtD
Etodolac—Dermatitis—Mitoxantrone—prostate cancer	2.71e-05	0.00025	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.71e-05	0.00025	CcSEcCtD
Etodolac—Headache—Mitoxantrone—prostate cancer	2.69e-05	0.000249	CcSEcCtD
Etodolac—Hypotension—Capecitabine—prostate cancer	2.69e-05	0.000248	CcSEcCtD
Etodolac—Insomnia—Docetaxel—prostate cancer	2.69e-05	0.000248	CcSEcCtD
Etodolac—Arthralgia—Prednisone—prostate cancer	2.67e-05	0.000247	CcSEcCtD
Etodolac—Myalgia—Prednisone—prostate cancer	2.67e-05	0.000247	CcSEcCtD
Etodolac—Paraesthesia—Docetaxel—prostate cancer	2.67e-05	0.000246	CcSEcCtD
Etodolac—Erythema multiforme—Epirubicin—prostate cancer	2.67e-05	0.000246	CcSEcCtD
Etodolac—Anxiety—Prednisone—prostate cancer	2.67e-05	0.000246	CcSEcCtD
Etodolac—Dyspnoea—Docetaxel—prostate cancer	2.65e-05	0.000244	CcSEcCtD
Etodolac—Somnolence—Docetaxel—prostate cancer	2.64e-05	0.000244	CcSEcCtD
Etodolac—Discomfort—Prednisone—prostate cancer	2.64e-05	0.000244	CcSEcCtD
Etodolac—Hypersensitivity—Etoposide—prostate cancer	2.64e-05	0.000243	CcSEcCtD
Etodolac—Tinnitus—Epirubicin—prostate cancer	2.63e-05	0.000243	CcSEcCtD
Etodolac—Haemoglobin—Doxorubicin—prostate cancer	2.62e-05	0.000242	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.62e-05	0.000242	CcSEcCtD
Etodolac—Flushing—Epirubicin—prostate cancer	2.62e-05	0.000242	CcSEcCtD
Etodolac—Rhinitis—Doxorubicin—prostate cancer	2.62e-05	0.000242	CcSEcCtD
Etodolac—Dyspepsia—Docetaxel—prostate cancer	2.62e-05	0.000241	CcSEcCtD
Etodolac—Haemorrhage—Doxorubicin—prostate cancer	2.61e-05	0.000241	CcSEcCtD
Etodolac—Hepatitis—Doxorubicin—prostate cancer	2.61e-05	0.000241	CcSEcCtD
Etodolac—Insomnia—Capecitabine—prostate cancer	2.6e-05	0.00024	CcSEcCtD
Etodolac—Pharyngitis—Doxorubicin—prostate cancer	2.59e-05	0.000239	CcSEcCtD
Etodolac—Paraesthesia—Capecitabine—prostate cancer	2.58e-05	0.000238	CcSEcCtD
Etodolac—Decreased appetite—Docetaxel—prostate cancer	2.58e-05	0.000238	CcSEcCtD
Etodolac—Asthenia—Etoposide—prostate cancer	2.57e-05	0.000237	CcSEcCtD
Etodolac—Dyspnoea—Capecitabine—prostate cancer	2.57e-05	0.000237	CcSEcCtD
Etodolac—Anaphylactic shock—Prednisone—prostate cancer	2.56e-05	0.000237	CcSEcCtD
Etodolac—Oedema—Prednisone—prostate cancer	2.56e-05	0.000237	CcSEcCtD
Etodolac—Fatigue—Docetaxel—prostate cancer	2.56e-05	0.000236	CcSEcCtD
Etodolac—Nausea—Mitoxantrone—prostate cancer	2.55e-05	0.000236	CcSEcCtD
Etodolac—Infection—Prednisone—prostate cancer	2.55e-05	0.000235	CcSEcCtD
Etodolac—Constipation—Docetaxel—prostate cancer	2.54e-05	0.000235	CcSEcCtD
Etodolac—Pain—Docetaxel—prostate cancer	2.54e-05	0.000235	CcSEcCtD
Etodolac—Dyspepsia—Capecitabine—prostate cancer	2.53e-05	0.000234	CcSEcCtD
Etodolac—Chills—Epirubicin—prostate cancer	2.53e-05	0.000234	CcSEcCtD
Etodolac—Pruritus—Etoposide—prostate cancer	2.53e-05	0.000233	CcSEcCtD
Etodolac—Shock—Prednisone—prostate cancer	2.52e-05	0.000233	CcSEcCtD
Etodolac—Arrhythmia—Epirubicin—prostate cancer	2.52e-05	0.000233	CcSEcCtD
Etodolac—Visual impairment—Doxorubicin—prostate cancer	2.52e-05	0.000232	CcSEcCtD
Etodolac—Tachycardia—Prednisone—prostate cancer	2.5e-05	0.000231	CcSEcCtD
Etodolac—Decreased appetite—Capecitabine—prostate cancer	2.5e-05	0.000231	CcSEcCtD
Etodolac—Alopecia—Epirubicin—prostate cancer	2.49e-05	0.00023	CcSEcCtD
Etodolac—Fatigue—Capecitabine—prostate cancer	2.48e-05	0.000229	CcSEcCtD
Etodolac—Hyperhidrosis—Prednisone—prostate cancer	2.48e-05	0.000229	CcSEcCtD
Etodolac—Erythema multiforme—Doxorubicin—prostate cancer	2.47e-05	0.000228	CcSEcCtD
Etodolac—Pain—Capecitabine—prostate cancer	2.46e-05	0.000227	CcSEcCtD
Etodolac—Constipation—Capecitabine—prostate cancer	2.46e-05	0.000227	CcSEcCtD
Etodolac—Feeling abnormal—Docetaxel—prostate cancer	2.45e-05	0.000226	CcSEcCtD
Etodolac—Diarrhoea—Etoposide—prostate cancer	2.45e-05	0.000226	CcSEcCtD
Etodolac—Anorexia—Prednisone—prostate cancer	2.44e-05	0.000225	CcSEcCtD
Etodolac—Tinnitus—Doxorubicin—prostate cancer	2.43e-05	0.000225	CcSEcCtD
Etodolac—Gastrointestinal pain—Docetaxel—prostate cancer	2.43e-05	0.000224	CcSEcCtD
Etodolac—Flushing—Doxorubicin—prostate cancer	2.42e-05	0.000224	CcSEcCtD
Etodolac—Flatulence—Epirubicin—prostate cancer	2.42e-05	0.000223	CcSEcCtD
Etodolac—Tension—Epirubicin—prostate cancer	2.41e-05	0.000222	CcSEcCtD
Etodolac—Dysgeusia—Epirubicin—prostate cancer	2.41e-05	0.000222	CcSEcCtD
Etodolac—Nervousness—Epirubicin—prostate cancer	2.39e-05	0.00022	CcSEcCtD
Etodolac—Feeling abnormal—Capecitabine—prostate cancer	2.37e-05	0.000219	CcSEcCtD
Etodolac—Dizziness—Etoposide—prostate cancer	2.37e-05	0.000218	CcSEcCtD
Etodolac—Gastrointestinal pain—Capecitabine—prostate cancer	2.35e-05	0.000217	CcSEcCtD
Etodolac—Abdominal pain—Docetaxel—prostate cancer	2.35e-05	0.000217	CcSEcCtD
Etodolac—Body temperature increased—Docetaxel—prostate cancer	2.35e-05	0.000217	CcSEcCtD
Etodolac—Chills—Doxorubicin—prostate cancer	2.34e-05	0.000216	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Prednisone—prostate cancer	2.34e-05	0.000215	CcSEcCtD
Etodolac—Arrhythmia—Doxorubicin—prostate cancer	2.33e-05	0.000215	CcSEcCtD
Etodolac—Insomnia—Prednisone—prostate cancer	2.32e-05	0.000214	CcSEcCtD
Etodolac—Vision blurred—Epirubicin—prostate cancer	2.32e-05	0.000214	CcSEcCtD
Etodolac—Alopecia—Doxorubicin—prostate cancer	2.31e-05	0.000213	CcSEcCtD
Etodolac—Paraesthesia—Prednisone—prostate cancer	2.3e-05	0.000212	CcSEcCtD
Etodolac—Urticaria—Capecitabine—prostate cancer	2.29e-05	0.000211	CcSEcCtD
Etodolac—Ill-defined disorder—Epirubicin—prostate cancer	2.28e-05	0.00021	CcSEcCtD
Etodolac—Abdominal pain—Capecitabine—prostate cancer	2.28e-05	0.00021	CcSEcCtD
Etodolac—Body temperature increased—Capecitabine—prostate cancer	2.28e-05	0.00021	CcSEcCtD
Etodolac—Vomiting—Etoposide—prostate cancer	2.27e-05	0.00021	CcSEcCtD
Etodolac—Anaemia—Epirubicin—prostate cancer	2.27e-05	0.000209	CcSEcCtD
Etodolac—Dyspepsia—Prednisone—prostate cancer	2.26e-05	0.000208	CcSEcCtD
Etodolac—Rash—Etoposide—prostate cancer	2.26e-05	0.000208	CcSEcCtD
Etodolac—Dermatitis—Etoposide—prostate cancer	2.25e-05	0.000208	CcSEcCtD
Etodolac—Headache—Etoposide—prostate cancer	2.24e-05	0.000207	CcSEcCtD
Etodolac—Flatulence—Doxorubicin—prostate cancer	2.24e-05	0.000207	CcSEcCtD
Etodolac—Tension—Doxorubicin—prostate cancer	2.23e-05	0.000206	CcSEcCtD
Etodolac—Decreased appetite—Prednisone—prostate cancer	2.23e-05	0.000206	CcSEcCtD
Etodolac—Dysgeusia—Doxorubicin—prostate cancer	2.23e-05	0.000205	CcSEcCtD
Etodolac—Malaise—Epirubicin—prostate cancer	2.22e-05	0.000204	CcSEcCtD
Etodolac—Fatigue—Prednisone—prostate cancer	2.21e-05	0.000204	CcSEcCtD
Etodolac—Nervousness—Doxorubicin—prostate cancer	2.21e-05	0.000204	CcSEcCtD
Etodolac—Vertigo—Epirubicin—prostate cancer	2.21e-05	0.000204	CcSEcCtD
Etodolac—Syncope—Epirubicin—prostate cancer	2.2e-05	0.000203	CcSEcCtD
Etodolac—Leukopenia—Epirubicin—prostate cancer	2.2e-05	0.000203	CcSEcCtD
Etodolac—Constipation—Prednisone—prostate cancer	2.19e-05	0.000202	CcSEcCtD
Etodolac—Hypersensitivity—Docetaxel—prostate cancer	2.19e-05	0.000202	CcSEcCtD
Etodolac—Palpitations—Epirubicin—prostate cancer	2.17e-05	0.0002	CcSEcCtD
Etodolac—Loss of consciousness—Epirubicin—prostate cancer	2.16e-05	0.000199	CcSEcCtD
Etodolac—Vision blurred—Doxorubicin—prostate cancer	2.14e-05	0.000198	CcSEcCtD
Etodolac—Asthenia—Docetaxel—prostate cancer	2.13e-05	0.000197	CcSEcCtD
Etodolac—Convulsion—Epirubicin—prostate cancer	2.13e-05	0.000196	CcSEcCtD
Etodolac—Nausea—Etoposide—prostate cancer	2.12e-05	0.000196	CcSEcCtD
Etodolac—Hypertension—Epirubicin—prostate cancer	2.12e-05	0.000196	CcSEcCtD
Etodolac—Hypersensitivity—Capecitabine—prostate cancer	2.12e-05	0.000196	CcSEcCtD
Etodolac—Feeling abnormal—Prednisone—prostate cancer	2.11e-05	0.000195	CcSEcCtD
Etodolac—Ill-defined disorder—Doxorubicin—prostate cancer	2.11e-05	0.000195	CcSEcCtD
Etodolac—Pruritus—Docetaxel—prostate cancer	2.1e-05	0.000194	CcSEcCtD
Etodolac—Anaemia—Doxorubicin—prostate cancer	2.1e-05	0.000194	CcSEcCtD
Etodolac—Gastrointestinal pain—Prednisone—prostate cancer	2.1e-05	0.000193	CcSEcCtD
Etodolac—Arthralgia—Epirubicin—prostate cancer	2.09e-05	0.000193	CcSEcCtD
Etodolac—Myalgia—Epirubicin—prostate cancer	2.09e-05	0.000193	CcSEcCtD
Etodolac—Anxiety—Epirubicin—prostate cancer	2.08e-05	0.000192	CcSEcCtD
Etodolac—Discomfort—Epirubicin—prostate cancer	2.07e-05	0.000191	CcSEcCtD
Etodolac—Asthenia—Capecitabine—prostate cancer	2.07e-05	0.00019	CcSEcCtD
Etodolac—Malaise—Doxorubicin—prostate cancer	2.05e-05	0.000189	CcSEcCtD
Etodolac—Dry mouth—Epirubicin—prostate cancer	2.05e-05	0.000189	CcSEcCtD
Etodolac—Vertigo—Doxorubicin—prostate cancer	2.04e-05	0.000188	CcSEcCtD
Etodolac—Syncope—Doxorubicin—prostate cancer	2.04e-05	0.000188	CcSEcCtD
Etodolac—Urticaria—Prednisone—prostate cancer	2.04e-05	0.000188	CcSEcCtD
Etodolac—Pruritus—Capecitabine—prostate cancer	2.04e-05	0.000188	CcSEcCtD
Etodolac—Leukopenia—Doxorubicin—prostate cancer	2.03e-05	0.000188	CcSEcCtD
Etodolac—Diarrhoea—Docetaxel—prostate cancer	2.03e-05	0.000188	CcSEcCtD
Etodolac—Abdominal pain—Prednisone—prostate cancer	2.03e-05	0.000187	CcSEcCtD
Etodolac—Body temperature increased—Prednisone—prostate cancer	2.03e-05	0.000187	CcSEcCtD
Etodolac—Confusional state—Epirubicin—prostate cancer	2.02e-05	0.000187	CcSEcCtD
Etodolac—Palpitations—Doxorubicin—prostate cancer	2.01e-05	0.000185	CcSEcCtD
Etodolac—Oedema—Epirubicin—prostate cancer	2.01e-05	0.000185	CcSEcCtD
Etodolac—Anaphylactic shock—Epirubicin—prostate cancer	2.01e-05	0.000185	CcSEcCtD
Etodolac—Loss of consciousness—Doxorubicin—prostate cancer	2e-05	0.000184	CcSEcCtD
Etodolac—Infection—Epirubicin—prostate cancer	1.99e-05	0.000184	CcSEcCtD
Etodolac—Shock—Epirubicin—prostate cancer	1.97e-05	0.000182	CcSEcCtD
Etodolac—Convulsion—Doxorubicin—prostate cancer	1.97e-05	0.000182	CcSEcCtD
Etodolac—Diarrhoea—Capecitabine—prostate cancer	1.97e-05	0.000182	CcSEcCtD
Etodolac—Dizziness—Docetaxel—prostate cancer	1.97e-05	0.000181	CcSEcCtD
Etodolac—Thrombocytopenia—Epirubicin—prostate cancer	1.96e-05	0.000181	CcSEcCtD
Etodolac—Hypertension—Doxorubicin—prostate cancer	1.96e-05	0.000181	CcSEcCtD
Etodolac—Tachycardia—Epirubicin—prostate cancer	1.96e-05	0.000181	CcSEcCtD
Etodolac—Hyperhidrosis—Epirubicin—prostate cancer	1.94e-05	0.000179	CcSEcCtD
Etodolac—Arthralgia—Doxorubicin—prostate cancer	1.94e-05	0.000179	CcSEcCtD
Etodolac—Myalgia—Doxorubicin—prostate cancer	1.94e-05	0.000179	CcSEcCtD
Etodolac—Anxiety—Doxorubicin—prostate cancer	1.93e-05	0.000178	CcSEcCtD
Etodolac—Discomfort—Doxorubicin—prostate cancer	1.91e-05	0.000176	CcSEcCtD
Etodolac—Anorexia—Epirubicin—prostate cancer	1.91e-05	0.000176	CcSEcCtD
Etodolac—Dizziness—Capecitabine—prostate cancer	1.9e-05	0.000176	CcSEcCtD
Etodolac—Dry mouth—Doxorubicin—prostate cancer	1.89e-05	0.000175	CcSEcCtD
Etodolac—Vomiting—Docetaxel—prostate cancer	1.89e-05	0.000174	CcSEcCtD
Etodolac—Hypersensitivity—Prednisone—prostate cancer	1.89e-05	0.000174	CcSEcCtD
Etodolac—Rash—Docetaxel—prostate cancer	1.87e-05	0.000173	CcSEcCtD
Etodolac—Hypotension—Epirubicin—prostate cancer	1.87e-05	0.000173	CcSEcCtD
Etodolac—Dermatitis—Docetaxel—prostate cancer	1.87e-05	0.000173	CcSEcCtD
Etodolac—Confusional state—Doxorubicin—prostate cancer	1.87e-05	0.000173	CcSEcCtD
Etodolac—Headache—Docetaxel—prostate cancer	1.86e-05	0.000172	CcSEcCtD
Etodolac—Anaphylactic shock—Doxorubicin—prostate cancer	1.86e-05	0.000171	CcSEcCtD
Etodolac—Oedema—Doxorubicin—prostate cancer	1.86e-05	0.000171	CcSEcCtD
Etodolac—Infection—Doxorubicin—prostate cancer	1.84e-05	0.00017	CcSEcCtD
Etodolac—Asthenia—Prednisone—prostate cancer	1.84e-05	0.00017	CcSEcCtD
Etodolac—Vomiting—Capecitabine—prostate cancer	1.83e-05	0.000169	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.83e-05	0.000169	CcSEcCtD
Etodolac—Shock—Doxorubicin—prostate cancer	1.83e-05	0.000168	CcSEcCtD
Etodolac—Thrombocytopenia—Doxorubicin—prostate cancer	1.82e-05	0.000168	CcSEcCtD
Etodolac—Rash—Capecitabine—prostate cancer	1.81e-05	0.000167	CcSEcCtD
Etodolac—Pruritus—Prednisone—prostate cancer	1.81e-05	0.000167	CcSEcCtD
Etodolac—Insomnia—Epirubicin—prostate cancer	1.81e-05	0.000167	CcSEcCtD
Etodolac—Dermatitis—Capecitabine—prostate cancer	1.81e-05	0.000167	CcSEcCtD
Etodolac—Tachycardia—Doxorubicin—prostate cancer	1.81e-05	0.000167	CcSEcCtD
Etodolac—Headache—Capecitabine—prostate cancer	1.8e-05	0.000166	CcSEcCtD
Etodolac—Paraesthesia—Epirubicin—prostate cancer	1.8e-05	0.000166	CcSEcCtD
Etodolac—Hyperhidrosis—Doxorubicin—prostate cancer	1.79e-05	0.000165	CcSEcCtD
Etodolac—Dyspnoea—Epirubicin—prostate cancer	1.79e-05	0.000165	CcSEcCtD
Etodolac—Somnolence—Epirubicin—prostate cancer	1.78e-05	0.000164	CcSEcCtD
Etodolac—Anorexia—Doxorubicin—prostate cancer	1.77e-05	0.000163	CcSEcCtD
Etodolac—Nausea—Docetaxel—prostate cancer	1.77e-05	0.000163	CcSEcCtD
Etodolac—Dyspepsia—Epirubicin—prostate cancer	1.77e-05	0.000163	CcSEcCtD
Etodolac—Diarrhoea—Prednisone—prostate cancer	1.75e-05	0.000162	CcSEcCtD
Etodolac—Decreased appetite—Epirubicin—prostate cancer	1.74e-05	0.000161	CcSEcCtD
Etodolac—Hypotension—Doxorubicin—prostate cancer	1.73e-05	0.00016	CcSEcCtD
Etodolac—Fatigue—Epirubicin—prostate cancer	1.73e-05	0.000159	CcSEcCtD
Etodolac—Pain—Epirubicin—prostate cancer	1.71e-05	0.000158	CcSEcCtD
Etodolac—Constipation—Epirubicin—prostate cancer	1.71e-05	0.000158	CcSEcCtD
Etodolac—Nausea—Capecitabine—prostate cancer	1.71e-05	0.000158	CcSEcCtD
Etodolac—Dizziness—Prednisone—prostate cancer	1.7e-05	0.000156	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.69e-05	0.000156	CcSEcCtD
Etodolac—Insomnia—Doxorubicin—prostate cancer	1.68e-05	0.000155	CcSEcCtD
Etodolac—Paraesthesia—Doxorubicin—prostate cancer	1.67e-05	0.000154	CcSEcCtD
Etodolac—Dyspnoea—Doxorubicin—prostate cancer	1.65e-05	0.000153	CcSEcCtD
Etodolac—Feeling abnormal—Epirubicin—prostate cancer	1.65e-05	0.000152	CcSEcCtD
Etodolac—Somnolence—Doxorubicin—prostate cancer	1.65e-05	0.000152	CcSEcCtD
Etodolac—Gastrointestinal pain—Epirubicin—prostate cancer	1.64e-05	0.000151	CcSEcCtD
Etodolac—Dyspepsia—Doxorubicin—prostate cancer	1.63e-05	0.000151	CcSEcCtD
Etodolac—Vomiting—Prednisone—prostate cancer	1.63e-05	0.00015	CcSEcCtD
Etodolac—Rash—Prednisone—prostate cancer	1.62e-05	0.000149	CcSEcCtD
Etodolac—Dermatitis—Prednisone—prostate cancer	1.62e-05	0.000149	CcSEcCtD
Etodolac—Decreased appetite—Doxorubicin—prostate cancer	1.61e-05	0.000149	CcSEcCtD
Etodolac—Headache—Prednisone—prostate cancer	1.61e-05	0.000148	CcSEcCtD
Etodolac—Fatigue—Doxorubicin—prostate cancer	1.6e-05	0.000148	CcSEcCtD
Etodolac—Urticaria—Epirubicin—prostate cancer	1.59e-05	0.000147	CcSEcCtD
Etodolac—Constipation—Doxorubicin—prostate cancer	1.59e-05	0.000146	CcSEcCtD
Etodolac—Pain—Doxorubicin—prostate cancer	1.59e-05	0.000146	CcSEcCtD
Etodolac—Abdominal pain—Epirubicin—prostate cancer	1.59e-05	0.000146	CcSEcCtD
Etodolac—Body temperature increased—Epirubicin—prostate cancer	1.59e-05	0.000146	CcSEcCtD
Etodolac—Feeling abnormal—Doxorubicin—prostate cancer	1.53e-05	0.000141	CcSEcCtD
Etodolac—Nausea—Prednisone—prostate cancer	1.52e-05	0.00014	CcSEcCtD
Etodolac—Gastrointestinal pain—Doxorubicin—prostate cancer	1.52e-05	0.00014	CcSEcCtD
Etodolac—Hypersensitivity—Epirubicin—prostate cancer	1.48e-05	0.000136	CcSEcCtD
Etodolac—Urticaria—Doxorubicin—prostate cancer	1.47e-05	0.000136	CcSEcCtD
Etodolac—Body temperature increased—Doxorubicin—prostate cancer	1.47e-05	0.000135	CcSEcCtD
Etodolac—Abdominal pain—Doxorubicin—prostate cancer	1.47e-05	0.000135	CcSEcCtD
Etodolac—Asthenia—Epirubicin—prostate cancer	1.44e-05	0.000133	CcSEcCtD
Etodolac—Pruritus—Epirubicin—prostate cancer	1.42e-05	0.000131	CcSEcCtD
Etodolac—Diarrhoea—Epirubicin—prostate cancer	1.37e-05	0.000127	CcSEcCtD
Etodolac—Hypersensitivity—Doxorubicin—prostate cancer	1.37e-05	0.000126	CcSEcCtD
Etodolac—Asthenia—Doxorubicin—prostate cancer	1.33e-05	0.000123	CcSEcCtD
Etodolac—Dizziness—Epirubicin—prostate cancer	1.33e-05	0.000122	CcSEcCtD
Etodolac—Pruritus—Doxorubicin—prostate cancer	1.31e-05	0.000121	CcSEcCtD
Etodolac—Vomiting—Epirubicin—prostate cancer	1.27e-05	0.000118	CcSEcCtD
Etodolac—Diarrhoea—Doxorubicin—prostate cancer	1.27e-05	0.000117	CcSEcCtD
Etodolac—Rash—Epirubicin—prostate cancer	1.26e-05	0.000117	CcSEcCtD
Etodolac—Dermatitis—Epirubicin—prostate cancer	1.26e-05	0.000117	CcSEcCtD
Etodolac—Headache—Epirubicin—prostate cancer	1.26e-05	0.000116	CcSEcCtD
Etodolac—Dizziness—Doxorubicin—prostate cancer	1.23e-05	0.000113	CcSEcCtD
Etodolac—Nausea—Epirubicin—prostate cancer	1.19e-05	0.00011	CcSEcCtD
Etodolac—Vomiting—Doxorubicin—prostate cancer	1.18e-05	0.000109	CcSEcCtD
Etodolac—Rash—Doxorubicin—prostate cancer	1.17e-05	0.000108	CcSEcCtD
Etodolac—Dermatitis—Doxorubicin—prostate cancer	1.17e-05	0.000108	CcSEcCtD
Etodolac—Headache—Doxorubicin—prostate cancer	1.16e-05	0.000107	CcSEcCtD
Etodolac—Nausea—Doxorubicin—prostate cancer	1.1e-05	0.000102	CcSEcCtD
Etodolac—CYP2C9—Metabolism—PLCB2—prostate cancer	2.05e-06	2.13e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2C18—prostate cancer	2.05e-06	2.13e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LRP2—prostate cancer	2.05e-06	2.13e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ITPR1—prostate cancer	2.04e-06	2.12e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.04e-06	2.12e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TYMS—prostate cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CB—prostate cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP3A4—prostate cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTT1—prostate cancer	2.03e-06	2.1e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ACHE—prostate cancer	2.03e-06	2.1e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—prostate cancer	2.02e-06	2.09e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—P4HB—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTM1—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CAV1—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2A6—prostate cancer	2e-06	2.08e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1B1—prostate cancer	2e-06	2.07e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.99e-06	2.07e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—INS—prostate cancer	1.99e-06	2.07e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CD—prostate cancer	1.98e-06	2.06e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—LPL—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS3—prostate cancer	1.96e-06	2.04e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC22A1—prostate cancer	1.96e-06	2.03e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKR1C3—prostate cancer	1.95e-06	2.02e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CREBBP—prostate cancer	1.95e-06	2.02e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PRKACB—prostate cancer	1.94e-06	2.01e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.93e-06	2.01e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GGT1—prostate cancer	1.93e-06	2.01e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.92e-06	1.99e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP17A1—prostate cancer	1.92e-06	1.99e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—JAK2—prostate cancer	1.91e-06	1.98e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SULT2A1—prostate cancer	1.91e-06	1.98e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1A1—prostate cancer	1.9e-06	1.98e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NCOA1—prostate cancer	1.9e-06	1.98e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.9e-06	1.97e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.89e-06	1.97e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ERCC2—prostate cancer	1.89e-06	1.96e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP19A1—prostate cancer	1.88e-06	1.95e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MED12—prostate cancer	1.88e-06	1.95e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NOS3—prostate cancer	1.87e-06	1.94e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—LPL—prostate cancer	1.87e-06	1.94e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GNG5—prostate cancer	1.86e-06	1.93e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PDGFRB—prostate cancer	1.85e-06	1.92e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CD—prostate cancer	1.85e-06	1.92e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CG—prostate cancer	1.83e-06	1.9e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NCOA2—prostate cancer	1.83e-06	1.9e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CB—prostate cancer	1.81e-06	1.88e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—RXRA—prostate cancer	1.81e-06	1.88e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NCOA3—prostate cancer	1.79e-06	1.86e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERCC2—prostate cancer	1.79e-06	1.86e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MTHFR—prostate cancer	1.78e-06	1.84e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.76e-06	1.83e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.76e-06	1.83e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—prostate cancer	1.75e-06	1.82e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB3—prostate cancer	1.75e-06	1.82e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.75e-06	1.82e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGFR2—prostate cancer	1.75e-06	1.82e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NOS3—prostate cancer	1.74e-06	1.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—COMT—prostate cancer	1.74e-06	1.81e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC5A5—prostate cancer	1.74e-06	1.81e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARA—prostate cancer	1.74e-06	1.81e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTP1—prostate cancer	1.74e-06	1.8e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—INS—prostate cancer	1.73e-06	1.8e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CB—prostate cancer	1.73e-06	1.79e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—prostate cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HPGDS—prostate cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ITPR1—prostate cancer	1.71e-06	1.77e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2E1—prostate cancer	1.7e-06	1.77e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2C19—prostate cancer	1.7e-06	1.77e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CREBBP—prostate cancer	1.7e-06	1.76e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NQO1—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTHFR—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.68e-06	1.74e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TERT—prostate cancer	1.68e-06	1.74e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—EP300—prostate cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—prostate cancer	1.66e-06	1.73e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—TH—prostate cancer	1.66e-06	1.72e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTT1—prostate cancer	1.66e-06	1.72e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ACHE—prostate cancer	1.66e-06	1.72e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.65e-06	1.71e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP3A4—prostate cancer	1.64e-06	1.71e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.64e-06	1.7e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CAV1—prostate cancer	1.64e-06	1.7e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.63e-06	1.7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.63e-06	1.7e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1B1—prostate cancer	1.61e-06	1.68e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TYMS—prostate cancer	1.61e-06	1.68e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CB—prostate cancer	1.61e-06	1.67e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CD—prostate cancer	1.61e-06	1.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HIF1A—prostate cancer	1.61e-06	1.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTM1—prostate cancer	1.6e-06	1.66e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—prostate cancer	1.6e-06	1.66e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.59e-06	1.66e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PRKACB—prostate cancer	1.59e-06	1.65e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.57e-06	1.63e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LPL—prostate cancer	1.57e-06	1.63e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.56e-06	1.63e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GGT1—prostate cancer	1.56e-06	1.62e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CAV1—prostate cancer	1.55e-06	1.61e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.55e-06	1.61e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NCOA1—prostate cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NOS3—prostate cancer	1.52e-06	1.58e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP19A1—prostate cancer	1.52e-06	1.58e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1A1—prostate cancer	1.51e-06	1.57e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ERCC2—prostate cancer	1.5e-06	1.56e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NCOA2—prostate cancer	1.5e-06	1.55e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—EP300—prostate cancer	1.49e-06	1.55e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CG—prostate cancer	1.49e-06	1.55e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—prostate cancer	1.49e-06	1.55e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—prostate cancer	1.49e-06	1.54e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—RXRA—prostate cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—BAD—prostate cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SRC—prostate cancer	1.45e-06	1.51e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.43e-06	1.48e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.42e-06	1.48e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—EP300—prostate cancer	1.42e-06	1.48e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APC—prostate cancer	1.41e-06	1.47e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—prostate cancer	1.41e-06	1.47e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—INS—prostate cancer	1.41e-06	1.47e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—COMT—prostate cancer	1.41e-06	1.47e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MTHFR—prostate cancer	1.41e-06	1.46e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTP1—prostate cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CB—prostate cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IRS1—prostate cancer	1.4e-06	1.45e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGF—prostate cancer	1.4e-06	1.45e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.39e-06	1.45e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—prostate cancer	1.39e-06	1.45e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—prostate cancer	1.39e-06	1.44e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CREBBP—prostate cancer	1.38e-06	1.44e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARA—prostate cancer	1.38e-06	1.44e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ITPR1—prostate cancer	1.38e-06	1.44e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NQO1—prostate cancer	1.38e-06	1.43e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TH—prostate cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—GSK3B—prostate cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.35e-06	1.4e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—INS—prostate cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.34e-06	1.39e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—EP300—prostate cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CD—prostate cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CREBBP—prostate cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—TYMS—prostate cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CAV1—prostate cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—prostate cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTM1—prostate cancer	1.29e-06	1.34e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GGT1—prostate cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—LPL—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NCOA1—prostate cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAP2K1—prostate cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CD—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NOS3—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SERPINE1—prostate cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1A1—prostate cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ERCC2—prostate cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—prostate cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—prostate cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—RXRA—prostate cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGF2—prostate cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CG—prostate cancer	1.18e-06	1.23e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS3—prostate cancer	1.17e-06	1.22e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—EP300—prostate cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—COMT—prostate cancer	1.15e-06	1.2e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTP1—prostate cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CB—prostate cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—JAK2—prostate cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—MTHFR—prostate cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—prostate cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ITPR1—prostate cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—INS—prostate cancer	1.12e-06	1.16e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARA—prostate cancer	1.12e-06	1.16e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MDM2—prostate cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—prostate cancer	1.1e-06	1.15e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CREBBP—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CB—prostate cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TYMS—prostate cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—prostate cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTM1—prostate cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—prostate cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CAV1—prostate cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CD—prostate cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LPL—prostate cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—prostate cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1B—prostate cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—prostate cancer	1.01e-06	1.05e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1A1—prostate cancer	1e-06	1.04e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ERCC2—prostate cancer	9.93e-07	1.03e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—prostate cancer	9.88e-07	1.03e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NOS3—prostate cancer	9.83e-07	1.02e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—prostate cancer	9.81e-07	1.02e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CTNNB1—prostate cancer	9.61e-07	9.98e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CG—prostate cancer	9.58e-07	9.96e-06	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—EP300—prostate cancer	9.42e-07	9.79e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN1A—prostate cancer	9.39e-07	9.75e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—prostate cancer	9.36e-07	9.73e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MTHFR—prostate cancer	9.34e-07	9.7e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARA—prostate cancer	9.16e-07	9.52e-06	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CB—prostate cancer	9.08e-07	9.43e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—INS—prostate cancer	9.07e-07	9.42e-06	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—prostate cancer	9.02e-07	9.37e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—EP300—prostate cancer	8.93e-07	9.28e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—CREBBP—prostate cancer	8.88e-07	9.23e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—SRC—prostate cancer	8.68e-07	9.02e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CAV1—prostate cancer	8.61e-07	8.95e-06	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—prostate cancer	8.59e-07	8.93e-06	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—prostate cancer	8.55e-07	8.88e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CD—prostate cancer	8.42e-07	8.75e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—prostate cancer	8.38e-07	8.7e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	8.23e-07	8.55e-06	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—prostate cancer	8.02e-07	8.33e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—NOS3—prostate cancer	7.95e-07	8.26e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CG—prostate cancer	7.84e-07	8.15e-06	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—prostate cancer	7.84e-07	8.15e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—prostate cancer	7.78e-07	8.08e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—prostate cancer	7.76e-07	8.07e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—prostate cancer	7.61e-07	7.91e-06	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—EP300—prostate cancer	7.48e-07	7.77e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—INS—prostate cancer	7.42e-07	7.71e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CB—prostate cancer	7.34e-07	7.63e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—prostate cancer	7.28e-07	7.56e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CREBBP—prostate cancer	7.27e-07	7.56e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—prostate cancer	7.19e-07	7.47e-06	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—prostate cancer	6.98e-07	7.26e-06	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—prostate cancer	6.97e-07	7.24e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CD—prostate cancer	6.9e-07	7.16e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—prostate cancer	6.61e-07	6.86e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NOS3—prostate cancer	6.51e-07	6.76e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—prostate cancer	6.34e-07	6.59e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—EP300—prostate cancer	6.05e-07	6.29e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.01e-07	6.24e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—prostate cancer	5.96e-07	6.19e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—prostate cancer	5.85e-07	6.08e-06	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—prostate cancer	5.69e-07	5.91e-06	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—prostate cancer	5.53e-07	5.75e-06	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—prostate cancer	5.4e-07	5.61e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—prostate cancer	5.19e-07	5.4e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—EP300—prostate cancer	4.95e-07	5.15e-06	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—prostate cancer	4.52e-07	4.7e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—prostate cancer	4.48e-07	4.65e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.66e-07	3.81e-06	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—prostate cancer	3.66e-07	3.8e-06	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—prostate cancer	2.99e-07	3.11e-06	CbGpPWpGaD
